• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

考虑行预防性输卵管卵巢切除术的东南亚 BRCA 突变携带者的需求:一项定性研究。

The needs of Southeast Asian BRCA mutation carriers considering risk-reducing salpingo-oophorectomy: a qualitative study.

机构信息

Department of Surgery, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia.

Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

出版信息

Fam Cancer. 2022 Jan;21(1):21-33. doi: 10.1007/s10689-021-00232-6. Epub 2021 Feb 19.

DOI:10.1007/s10689-021-00232-6
PMID:33604745
Abstract

The decision to have risk-reducing salpingo-oophorectomy (RRSO) by BRCA mutation carriers to reduce the risk of ovarian cancer is difficult. The choice involves trade-offs in terms of its risks and benefits. To date, understanding the decision-making needs of RRSO among Southeast Asian BRCA mutation carriers is limited. This study aimed to explore the decision-making needs of Malaysian BRCA mutation carriers as an exemplar for the Southeast Asian community. In-depth interviews and clinic observations were conducted with 31 BRCA mutation carriers and analysed thematically. The core theme identified was 'Coping with complex information and alleviating uncertainties' with the following subthemes: (1) the need for an adjustment period, (2) information support, (3) social support and, (4) religious support. We found that women required time to accept their BRCA mutation status before they were ready to make a risk-reducing choice; that understanding complex genetic information and multiple risk management options can be an overwhelming experience; and obtaining further information and a second opinion were challenging. Many described the need for experiential information from other peer-carriers who had undergone RRSO. Support from their spouse and family members was thought to be essential for them to feel reassured with their decision. Many relied on religion to positively cope with cancer risk and cancer worry; Muslim BRCA carriers sought religious guidance through prayers and Islamic fatwas to feel more certain about their RRSO decision. These findings underscore the importance of the provision of resources and support that includes input from peers, husband, family members and religion to underpin the decision-making needs of Malaysian BRCA mutation carriers considering RRSO.

摘要

进行 BRCA 基因突变携带者的预防性输卵管卵巢切除术(RRSO)以降低卵巢癌风险的决策是困难的。该选择涉及到风险和收益的权衡。迄今为止,对于东南亚 BRCA 基因突变携带者 RRSO 的决策需求的理解是有限的。本研究旨在探索马来西亚 BRCA 基因突变携带者的决策需求,以作为东南亚社区的范例。对 31 名 BRCA 基因突变携带者进行了深入访谈和临床观察,并进行了主题分析。确定的核心主题是“应对复杂信息和减轻不确定性”,其下有以下几个方面:(1)调整期的需求;(2)信息支持;(3)社会支持;(4)宗教支持。我们发现,女性在准备做出降低风险的选择之前,需要时间来接受自己的 BRCA 基因突变状况;理解复杂的遗传信息和多种风险管理选择可能是一种压倒性的体验;获得更多信息和第二意见是具有挑战性的。许多人描述了从已经接受 RRSO 的其他同行携带者那里获得经验信息的需求。配偶和家庭成员的支持被认为对她们做出决定感到放心是至关重要的。许多人依靠宗教来积极应对癌症风险和癌症担忧;穆斯林 BRCA 携带者通过祈祷和伊斯兰教法来寻求宗教指导,以对 RRSO 决策感到更加确定。这些发现强调了提供资源和支持的重要性,包括同行、丈夫、家庭成员和宗教的意见,以满足马来西亚 BRCA 基因突变携带者 RRSO 决策的需求。

相似文献

1
The needs of Southeast Asian BRCA mutation carriers considering risk-reducing salpingo-oophorectomy: a qualitative study.考虑行预防性输卵管卵巢切除术的东南亚 BRCA 突变携带者的需求:一项定性研究。
Fam Cancer. 2022 Jan;21(1):21-33. doi: 10.1007/s10689-021-00232-6. Epub 2021 Feb 19.
2
Decision-making for Risk-reducing Salpingo-oophorectomy (RRSO) in Southeast Asian BRCA Mutation Carriers With Breast Cancer: A Qualitative Study.东南亚携带 BRCA 基因突变乳腺癌患者行预防性输卵管卵巢切除术(RRSO)决策的定性研究。
Int J Behav Med. 2022 Feb;29(1):1-13. doi: 10.1007/s12529-021-09984-y. Epub 2021 Mar 31.
3
Surgical decision making in premenopausal carriers considering risk-reducing early salpingectomy or salpingo-oophorectomy: a qualitative study.考虑行预防性输卵管切除术或输卵管卵巢切除术降低风险的绝经前携带者的手术决策:一项定性研究。
J Med Genet. 2022 Feb;59(2):122-132. doi: 10.1136/jmedgenet-2020-107501. Epub 2021 Feb 10.
4
Satisfaction with prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers is very high and little dependent on the participants' characteristics at surgery: a prospective study.预防性降低风险的输卵管卵巢切除术在 BRCA 基因突变携带者中的满意度非常高,且与手术时患者的特征相关性很小:一项前瞻性研究。
Menopause. 2021 Feb 1;28(3):263-270. doi: 10.1097/GME.0000000000001737.
5
Pathologic findings at risk-reducing salpingo-oophorectomy (RRSO) in germline BRCA mutation carriers with breast cancer: significance of bilateral RRSO at the optimal age in germline BRCA mutation carriers.携带种系BRCA突变的乳腺癌患者行降低风险的输卵管卵巢切除术(RRSO)时的病理发现:种系BRCA突变携带者在最佳年龄行双侧RRSO的意义。
J Gynecol Oncol. 2017 Jan;28(1):e3. doi: 10.3802/jgo.2017.28.e3. Epub 2016 Aug 8.
6
Uptake of risk-reducing salpingo-oophorectomy among female BRCA mutation carriers: experience at the National Cancer Center of Korea.韩国国家癌症中心女性 BRCA 突变携带者进行降低风险的输卵管卵巢切除术的情况:经验总结
J Cancer Res Clin Oncol. 2016 Jan;142(1):333-40. doi: 10.1007/s00432-015-2051-x. Epub 2015 Oct 5.
7
Factors affecting the decision to undergo risk-reducing salpingo-oophorectomy among women with BRCA gene mutation.影响携带 BRCA 基因突变女性行预防性输卵管卵巢切除术决策的因素。
Fam Cancer. 2013 Dec;12(4):621-8. doi: 10.1007/s10689-013-9625-z.
8
Risk-reducing salpingo-oophorectomy for Japanese women with hereditary breast and ovarian cancer: a single-institution 10-year experience.遗传性乳腺癌和卵巢癌日本女性的预防性输卵管卵巢切除术:单机构 10 年经验。
Jpn J Clin Oncol. 2023 Jun 1;53(6):472-479. doi: 10.1093/jjco/hyad020.
9
Use of total abdominal hysterectomy and hormone replacement therapy in BRCA1 and BRCA2 mutation carriers undergoing risk-reducing salpingo-oophorectomy.在接受降低风险的输卵管卵巢切除术的BRCA1和BRCA2突变携带者中全腹子宫切除术和激素替代疗法的应用。
Fam Cancer. 2009;8(1):23-8. doi: 10.1007/s10689-008-9208-6. Epub 2008 Aug 29.
10
Prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers: what is going on in a region of northern Italy?预防性降低风险的输卵管卵巢切除术在 BRCA 基因突变携带者中的应用:意大利北部地区的情况如何?
Maturitas. 2021 Jan;143:59-64. doi: 10.1016/j.maturitas.2020.08.011. Epub 2020 Aug 31.

引用本文的文献

1
Shared decision-making in Malaysia: Legislation, patient involvement, implementation and the impact of COVID-19.马来西亚的共享决策:立法、患者参与、实施情况以及 COVID-19 的影响。
Z Evid Fortbild Qual Gesundhwes. 2022 Jun;171:89-92. doi: 10.1016/j.zefq.2022.04.020. Epub 2022 May 21.

本文引用的文献

1
International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation.具有 BRCA1 或 BRCA2 突变的女性中采用癌症风险降低策略的国际趋势。
Br J Cancer. 2019 Jul;121(1):15-21. doi: 10.1038/s41416-019-0446-1. Epub 2019 Apr 11.
2
The influence of Malay cultural beliefs on breast cancer screening and genetic testing: A focus group study.马来族文化信仰对乳腺癌筛查和基因检测的影响:一项焦点小组研究。
Psychooncology. 2018 Dec;27(12):2855-2861. doi: 10.1002/pon.4902. Epub 2018 Oct 16.
3
A case-control study of breast cancer risk factors in 7,663 women in Malaysia.
马来西亚 7663 名女性乳腺癌危险因素的病例对照研究。
PLoS One. 2018 Sep 14;13(9):e0203469. doi: 10.1371/journal.pone.0203469. eCollection 2018.
4
Breast and ovarian cancer penetrance of mutations among Hong Kong women.香港女性中乳腺癌和卵巢癌基因突变的外显率
Oncotarget. 2018 Feb 2;9(38):25025-25033. doi: 10.18632/oncotarget.24382. eCollection 2018 May 18.
5
Screening for Ovarian Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.卵巢癌筛查:美国预防服务工作组的更新证据报告和系统评价。
JAMA. 2018 Feb 13;319(6):595-606. doi: 10.1001/jama.2017.21421.
6
Autonomy and couples' joint decision-making in healthcare.医疗保健中的自主性与夫妻共同决策
BMC Med Ethics. 2018 Jan 11;19(1):3. doi: 10.1186/s12910-017-0241-6.
7
Use of Complementary and Alternative Medicine Among Newly Diagnosed Breast Cancer Patients in Malaysia: An Early Report From the MyBCC Study.马来西亚新诊断乳腺癌患者补充和替代医学的使用情况:MyBCC研究的早期报告
Integr Cancer Ther. 2018 Jun;17(2):312-321. doi: 10.1177/1534735417745248. Epub 2017 Dec 8.
8
Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan.日本遗传性乳腺癌和卵巢癌的遗传和临床特征:日本 HBOC 注册系统建立后的首次报告。
J Hum Genet. 2018 Apr;63(4):447-457. doi: 10.1038/s10038-017-0355-1. Epub 2017 Nov 8.
9
Who Decides: Me or We? Family Involvement in Medical Decision Making in Eastern and Western Countries.谁来决定:我还是我们?东西方国家医疗决策中的家庭参与
Med Decis Making. 2018 Jan;38(1):14-25. doi: 10.1177/0272989X17715628. Epub 2017 Jul 8.
10
The state of shared decision making in Malaysia.马来西亚的共同决策状态。
Z Evid Fortbild Qual Gesundhwes. 2017 Jun;123-124:66-68. doi: 10.1016/j.zefq.2017.05.019. Epub 2017 May 18.